Emerging Therapeutics for Immune Tolerance: Tolerogenic Vaccines, T cell Therapy, and IL-2 Therapy

por Moorman, Cody D., Sohn, Sue J., Phee, Hyewon
Publicado 2021

Dynamic changes in the regulatory T-cell heterogeneity and function by murine IL-2 mutein

por Lu, Daniel R, Wu, Hao, Driver, Ian, Ingersoll, Sarah, Sohn, Sue, Wang, Songli, Li, Chi-Ming, Phee, Hyewon
Publicado 2020

Defining the Threshold IL-2 Signal Required for Induction of Selective Treg Cell Responses Using Engineered IL-2 Muteins

por Ghelani, Aazam, Bates, Darren, Conner, Kip, Wu, Min-Zu, Lu, Jiamiao, Hu, Yi-Ling, Li, Chi-Ming, Chaudhry, Ashutosh, Sohn, Sue J.
Publicado 2020

Functional Studies on the IBD Susceptibility Gene IL23R Implicate Reduced Receptor Function in the Protective Genetic Variant R381Q

por Pidasheva, Svetlana, Trifari, Sara, Phillips, Anne, Hackney, Jason A., Ma, Yan, Smith, Ashley, Sohn, Sue J., Spits, Hergen, Little, Randall D., Behrens, Timothy W., Honigberg, Lee, Ghilardi, Nico, Clark, Hilary F.
Publicado 2011

Attenuated IL-2 muteins leverage the TCR signal to enhance regulatory T cell homeostasis and response in vivo

por Ma, Shining, So, Michelle, Ghelani, Aazam, Srivas, Rohith, Sahoo, Anupama, Hall, Robyn, Liu, Wenjun, Wu, Hao, Yu, Sherman, Lu, Shiping, Song, Elly, Cariaga, Taryn, Soto, Marcus, Zhou, Hong, Li, Chi-Ming, Chaudhry, Ashutosh, Luo, Xin, Sohn, Sue J.
Publicado 2023